Nevertheless, the inhibitor was still effective at blocking LMP7 specific enzymatic activity at concentrations where melanoma cells remained viable, which varied depending on the cell line used (Additional file 2: Figure S2c). This evidence concerns the gene PSMB8 and melanoma.